These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2910964)

  • 41. Androgenetic alopecia: an evidence-based treatment update.
    Varothai S; Bergfeld WF
    Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
    Roberts J; Desai N; McCoy J; Goren A
    Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topical minoxidil: review of efficacy and safety.
    Katz HI
    Cutis; 1989 Jan; 43(1):94-8. PubMed ID: 2644080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alopecia in congenital hidrotic ectodermal dysplasia responding to treatment with a combination of topical minoxidil and tretinoin.
    Melkote S; Dhurat RS; Palav A; Jerajani HR
    Int J Dermatol; 2009 Feb; 48(2):184-5. PubMed ID: 19200200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluation.
    El Taieb MA; Ibrahim H; Nada EA; Seif Al-Din M
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27791311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
    DeVillez RL; Jacobs JP; Szpunar CA; Warner ML
    Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil.
    Olsen EA; Weiner MS; Amara IA; DeLong ER
    J Am Acad Dermatol; 1990 Apr; 22(4):643-6. PubMed ID: 2180995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men.
    Hillmann K; Garcia Bartels N; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
    Skin Pharmacol Physiol; 2015; 28(5):236-44. PubMed ID: 25765348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
    Olsen EA; Carson SC; Turney EA
    Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial.
    Berger RS; Fu JL; Smiles KA; Turner CB; Schnell BM; Werchowski KM; Lammers KM
    Br J Dermatol; 2003 Aug; 149(2):354-62. PubMed ID: 12932243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The therapeutic use of topical minoxidil.
    DeVillez RL
    Dermatol Clin; 1990 Apr; 8(2):367-75. PubMed ID: 2191807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topical minoxidil dose-response effect in alopecia areata.
    Fiedler-Weiss VC; West DP; Buys CM; Rumsfield JA
    Arch Dermatol; 1986 Feb; 122(2):180-2. PubMed ID: 3947124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
    J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of 5% topical minoxidil versus 5 mg oral biotin versus topical minoxidil and oral biotin on hair growth in men: randomized, crossover, clinical trial.
    Valentim FO; Miola AC; Miot HA; Schmitt JV
    An Bras Dermatol; 2024; 99(4):581-584. PubMed ID: 38688776
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of oral minoxidil in the treatment of alopecia areata.
    Fiedler-Weiss VC; Rumsfield J; Buys CM; West DP; Wendrow A
    Arch Dermatol; 1987 Nov; 123(11):1488-90. PubMed ID: 3674909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and efficacy of topical minoxidil in the management of androgenetic alopecia.
    Rietschel RL; Duncan SH
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):677-85. PubMed ID: 3549802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized trial of minoxidil in chemotherapy-induced alopecia.
    Duvic M; Lemak NA; Valero V; Hymes SR; Farmer KL; Hortobagyi GN; Trancik RJ; Bandstra BA; Compton LD
    J Am Acad Dermatol; 1996 Jul; 35(1):74-8. PubMed ID: 8682968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is topical minoxidil solution effective on androgenetic alopecia in routine daily practice?
    Mapar MA; Omidian M
    J Dermatolog Treat; 2007; 18(5):268-70. PubMed ID: 17917938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of minoxidil topical foam on frontotemporal and vertex androgenetic alopecia in men: a 104-week open-label clinical trial.
    Kanti V; Hillmann K; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
    J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1183-9. PubMed ID: 26387973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Androgenetic alopecia and current methods of treatment.
    Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.